Risk of frailty in older women dependent on multisystem abnormalitiesJuly 31, 2009Study provides insights to the cause of frailty, as well as treatment and prevention A study published online ahead of press in the Gerontology Society of America's Journal of Gerontology: Medical Sciences reports that the condition of frailty in older adults is associated with a critical mass of abnormal physiological systems, over and above the status of each individual system, and that the relationship is nonlinear. This research is the first evidence that frailty is related to the number of abnormal physiological systems, rather than a specific system abnormality, a chronic disease, or chronological age. It suggests significant alterations in system biology with aging, and underlying frailty. Clinical implications are that prevention and treatment may be more likely to be effective if any given intervention improves multiple systems, not just one. According to the report, three or more systems at abnormal levels were significant predictors of being frail, and the dominating predictor was the number of systems abnormal, not any particular system. The study was based on data of women aged 70 - 79 years from the Women's Health and Aging Studies I and II and assesses the association of eight physiological measures with frailty. Abnormality in each system (anemia, inflammation, insulin-like growth factor-1, dehydroepiandrosterone-sulfate, hemoglobin A1c, micronutrients, adiposity, and fine motor speed) was significantly associated with frailty status. However, adjusting for the level of each system measure, the mean number of impaired systems significantly predicted frailty; only one system, fine motor speed, remained an independent predictor when the mass of systems abnormal was considered. The data indicate that half of those frail had three or more systems at abnormal levels, compared with 25% of the pre-frail and 16% of the non-frail. Less than 21% of the frail had zero or one system abnormal (of eight). Frail older adults are a group at increased risk of serious adverse clinical outcomes, including mortality, disability, falls, and loss of independence. Through the work of Dr. Fried and her colleagues at Johns Hopkins University, frailty has been defined to function as a distinct medical syndrome, which is clinically recognizable when a critical mass of symptoms and signs emerge. Frailty is recognized as the concurrent presence of three or more of the following: low strength, low energy, slowed motor performance, low physical activity, or unintentional weight loss. The findings outlined in the current paper build on Dr. Fried's body of work around frailty, and have significant applicability for the design of therapeutics, such as new drugs. "We found that the likelihood of frailty increases in relationship to the number of abnormal physiological systems, and the number of abnormal systems was strongly predictive of the likelihood of frailty, whereas the individual systems were not," says Linda P. Fried, MD, MPH, dean and DeLamar Professor of Public Health at the Columbia University Mailman School of Public Health and lead author. She adds, "It further suggests that therapeutic replacement of any one deficient system, such as testosterone, estrogen, or growth hormone, is unlikely to ameliorate or prevent frailty, unless it improves multiple physiologic systems. This may explainthe public health import of remaining physically active as we get older, since activity improves many aspects of biology and health." Given that many of the physiological systems evaluated affect or regulate each other, alteration of one may not be independent of another. These data suggest that acceleration of the likelihood of frailty may occur as the number of abnormal systems escalates, and suggests that there could be a threshold beyond which there is an adverse downward spiraling nature to the progression of frailty and its consequences. "The systems studied here have numerous physiological interconnections with each other," says Dr. Fried, "which would be consistent with the concept of 'majority rules' in systems biology-that past a critical level of dysregulation in physiological systems, the impaired systems may adversely affect other systems functioning at a normal level and bring the whole system to a more dysregulated state, with frailty as an outcome of a dysregulated complex system." "This research provides evidence of the interaction of a number of factors that contribute to frailty in older people," said Richard Suzman, PhD, director of the Division of Behavioral and Social Research at the National Institute on Aging, which funded the research. "It emphasizes the importance of considering frailty holistically." The number of chronic diseases was also a predictor of frailty, independent of the number of physiological systems at abnormal levels. This supports frailty as a final common pathway of multiple causes and that the burden of disease is a factor as well as aging-related physiological dysregulation. Columbia University's Mailman School of Public Health |
|||||||||||||||||||||
| Related Frailty Current Events and Frailty News Articles Stereotactic radiotherapy offers noninvasive, effective treatment for frail patients with early-stage lung cancer Stereotactic body radiation therapy (SBRT) should be considered a new standard of care for early-stage lung cancer treatment in patients with co-existing medical problems, according to results from a national clinical trial led by UT Southwestern Medical Center physicians. Calculate benefit before dialysis for frail elders Kidney specialists should weigh the potential quality of life for frail elders with end-stage renal disease (ESRD) in opting for dialysis over more conservative therapies, a nephrologist and a palliative care specialist suggest in an editorial in the New England Journal of Medicine. New research provides new insight into age-related muscle decline If you think the air outside is polluted, a new research report in the September 2009 issue of the journal Genetics might make you to think twice about the air inside our bodies too. Test detects molecular marker of aging in humans In 2004, researchers at the University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center announced a crucial discovery in the understanding of cellular aging. Appetite-stimulating hormone is first potential medical treatment for frailty in older women Older women suffering from clinical frailty stand to benefit from the first potential medical treatment for the condition, according to a study presented today by Penn Medicine researchers at ENDO, The Endocrine Society's 91st Annual Meeting. Hitting cancer where it hurts Two studies in the May 29th issue of Cell, a Cell Press publication, have taken advantage of new technological advances to search for and find previously unknown weaknesses in a hard to treat form of cancer. Elderly patients can benefit from selective use of early revascularization The elderly represent a growing proportion of patients presenting with acute myocardial infarction (MI) complicated by cardiogenic shock (CS). Diseased Heart Valve Replaced Through Small Chest Incision When 91-year-old Irvin Lafferty was diagnosed with severe blockage of his heart valve-hardening that is formally known as aortic valve stenosis-open-heart surgery was out of the question. Older women less likely than men to be listed for kidney transplants A Johns Hopkins transplant surgeon has found strong evidence that women over 45 are significantly less likely to be placed on a kidney transplant list than their equivalent male counterparts, even though women who receive a transplant stand an equal chance of survival. An Anti-Frailty Pill for Seniors? Researchers at the University of Virginia Health System report that a daily single oral dose of an investigational drug, MK-677, increased muscle mass in the arms and legs of healthy older adults without serious side effects, suggesting that it may prove safe and effective in reducing age-related frailty. More Frailty Current Events and Frailty News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||